Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Zometa Study in Pediatric Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of zoledronic acid (Zometa) in pediatric osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zometa (Zoledronic acid)

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED